On the other hand, our results show that the membrane receptor proteins participating in drug addiction pathways, such as nAChRs and μ opioid receptor (MOR), may be the potential target for therapeutic treatment for schizophrenia. The gene discussed is OPRM1; the disease is schizophrenia.